Skip to content

Study to evaluate analgesic efficacy between USG -guided transverse fascia plane block and conventional ilioinguinal/ iliohypogastric nerve block

Comparative study to evaluate analgesic efficacy between USG -guided transverse fascia plane block and conventional ilioinguinal/ iliohypogastric nerve block for inguinal surgeries -Prospective randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030775
Enrollment
80
Registered
2021-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ultrasound guided transverse fascia plane block: Patients will be randomly assigned by use of computer-generated random numbers into one of the groups. Group 1 will receive transversa

Sponsors

Super Speciality Paediatric Hospital and Post Graduate Teaching Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Scheduled for inguinal surgeries (inguinal surgery) 2 Age 12 months to 12 years 3. ASA physical status I or II

Exclusion criteria

Exclusion criteria: 1 Known contraindication to a peripheral nerve block such as severe coagulopathy 2 Allergy to amide local anesthetics 3 Local infection at the planned injection 4 Refusal by parents/guardians

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is to compare the duration of postoperative analgesia (time to first analgesic request)Timepoint: The primary outcome of the study is to compare the duration of postoperative analgesia (time to first analgesic request)

Secondary

MeasureTime frame
1. Intraoperative and postoperative hemodynamic stability 2. Intraoperative fentanyl consumption 3. Postoperative pain assessed by the FLACC score (children 4years) postoperatively at 0, 30min, 1, 2, 4, 6, 12, 18 and 24 hours 4. Untoward side effects, including nausea, vomiting, hypotension, bradycardia Timepoint: 6 months

Countries

India

Contacts

Public ContactRidhima

Superspeciality Paediatric hospital and Postgraduate teaching institute

drridhimasharma@yahoo.com08054549458

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026